对疟疾感染的抵抗力是由天然免疫组成部分的中间TCR细胞的NK1.1(+)和NK1.1(-)亚群共同作用实现的。
Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
作者信息
Mannoor M K, Weerasinghe A, Halder R C, Reza S, Morshed M, Ariyasinghe A, Watanabe H, Sekikawa H, Abo T
机构信息
Department of Immunology, Niigata University School of Medicine, Niigata, 951-8510, Japan.
出版信息
Cell Immunol. 2001 Aug 1;211(2):96-104. doi: 10.1006/cimm.2001.1833.
We previously reported that the major expanding lymphocytes were intermediate TCR (TCR(int)) cells (mainly NK1.1(-)) during malarial infection in mice. Cell transfer experiments of TCR(int) cells indicated that these T cells mediated resistance to malaria. However, TCR(int) cells always contain NK1.1(+)TCR(int) cells (i.e., NKT cells) and controversial results (NKT cells were effective or not for resistance to malaria) have been reported by different investigators. In this study, we used CD1d((-/-)) mice, which almost completely lack NKT cells in the liver and other immune organs. Parasitemia was prolonged in the blood of CD1d((-/-)) mice and the expansion of lymphocytes in the liver of these mice was more prominent after an injection of Plasmodium yoelii-infected erythrocytes. However, these mice finally recovered from malaria. In contrast to B6 mice, CD4(-)8(-) NKT cells as well as NK1.1(-)CD3(int) cells expanded in CD1d((-/-)) mice after malarial infection, instead of CD4(+) (and CD8(+)) NKT cells. These newly generated CD4(-)8(-)NKT cells in CD1d((-/-)) mice did not use an invariant chain of Valpha14Jalpha281 for TCRalpha. Other evidence was that severe thymic atrophy and autoantibody production were accompanied by malarial infection, irrespective of the mice used. These results suggest that both NK1.1(-) and NK1.1(+) subsets of TCR(int) cells (i.e., constituents of innate immunity) are associated with resistance to malaria and that an autoimmune-like state is induced during malarial infection.
我们之前报道过,在小鼠疟疾感染期间,主要扩增的淋巴细胞是中间型TCR(TCR(int))细胞(主要是NK1.1(-))。TCR(int)细胞的细胞转移实验表明,这些T细胞介导了对疟疾的抗性。然而,TCR(int)细胞总是包含NK1.1(+)TCR(int)细胞(即NKT细胞),并且不同研究者报道了有争议的结果(NKT细胞对疟疾抗性是否有效)。在本研究中,我们使用了CD1d((-/-))小鼠,其在肝脏和其他免疫器官中几乎完全缺乏NKT细胞。在注射约氏疟原虫感染的红细胞后,CD1d((-/-))小鼠血液中的疟原虫血症持续时间延长,并且这些小鼠肝脏中淋巴细胞的扩增更为显著。然而,这些小鼠最终从疟疾中恢复。与B6小鼠相反,疟疾感染后,CD1d((-/-))小鼠中CD4(-)8(-) NKT细胞以及NK1.1(-)CD3(int)细胞扩增,而不是CD4(+)(和CD8(+))NKT细胞。CD1d((-/-))小鼠中这些新产生的CD4(-)8(-)NKT细胞在TCRα中不使用不变链Valpha14Jalpha281。其他证据是,无论使用何种小鼠,疟疾感染都伴随着严重的胸腺萎缩和自身抗体产生。这些结果表明,TCR(int)细胞的NK1.1(-)和NK1.1(+)亚群(即固有免疫的组成部分)都与对疟疾的抗性相关,并且在疟疾感染期间会诱导类似自身免疫的状态。